Dr. Duan has over 15 years of experience in tumor molecular biology and has a broad background in chemical synthesis, nanotechnology, translational pharmacology, and clinical oncology. Throughout his postdoctoral work in Dr. Michael Seiden's (current President of Fox Chase Cancer Center) laboratory at MGH Cancer Center, he received extensive training in the field of cellular and molecular biology in human cancer. Currently, Dr. Duan's research focuses on understanding the mechanisms of multidrug resistance, drug formulations and delivery systems, and nanotechnology applications in cancer. His research group has made significant contributions to the areas of multidrug resistance, kinases and miRNAs of human cancer.